Providers should monitor residents with diabetes to see if they are using recalled blood glucose test trips, the U.S. Food and Drug Administration has advised.
Care improvements reduce amputations
By
John O'Connor
Aug 01, 2013
Advances in diabetic foot ulcer treatments are helping reduce lower-extremity amputations, a new study finds. Researchers at the University of Iowa Department of Orthopaedics and Rehabilitation studied...
Drug company to pay $3 billion to settle criminal charges
Jul 02, 2012
In what is the biggest healthcare fraud settlement in U.S. history, drugmaker GlaxoSmithKline will pay $3 billion and plead guilty to illegally promoting prescription drugs.
Popular diabetes medication linked to heart attack, death
Mar 22, 2011
A new study links the popular diabetes drug Avandia with an increased risk of heart attack and death, which could have a considerable effect on public health, according to researchers.
FDA approves ‘breakthrough’ therapy for diabetic eye disorder
By
John Hall
Mar 26, 2015
The FDA announced Wednesday that it has granted “breakthrough therapy designation” to the drug Eylea, and expanded its approved use for the treatment of diabetic retinopathy in patients with...